Literature DB >> 3362330

Infantile chronic subdural hematoma with local protrusion of the skull in a case of osteogenesis imperfecta.

K Tokoro1, F Nakajima, A Yamataki.   

Abstract

Osteogenesis imperfecta with infantile chronic subdural hematoma is extremely rare and has not been previously described in the literature. Our patient was a baby girl suffering from osteogenesis imperfecta tarda (Type I) who had an acute subdural hematoma at birth and who developed a progressive chronic subdural hematoma with local protrusion of the overlying skull. She was treated surgically with a good result. This rare complication is due to weakness of an insufficiently calcified skull, which is peculiar to this disorder of bone and connective tissue development.

Entities:  

Mesh:

Year:  1988        PMID: 3362330     DOI: 10.1227/00006123-198803000-00029

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  5 in total

1.  Arachnoid cyst and chronic subdural haematoma in a child with osteogenesis imperfecta type III resulting from the substitution of glycine 1006 by alanine in the pro alpha 2(I) chain of type I procollagen.

Authors:  W G Cole; T P Lam
Journal:  J Med Genet       Date:  1996-03       Impact factor: 6.318

2.  Osteogenesis Imperfecta and Extra-/Intradural Hematomas: A Case Report and Review of the Literature.

Authors:  Fatih Yakar; Emrah Celtikci; Onur Ozgural; Umit Eroglu; Yusuf Sukru Caglar
Journal:  J Pediatr Genet       Date:  2018-06-14

Review 3.  Abusive head trauma: neuroimaging mimics and diagnostic complexities.

Authors:  Jai Sidpra; Sahil Chhabda; Adam J Oates; Aashim Bhatia; Susan I Blaser; Kshitij Mankad
Journal:  Pediatr Radiol       Date:  2021-05-17

4.  Causes of death in osteogenesis imperfecta.

Authors:  S J McAllion; C R Paterson
Journal:  J Clin Pathol       Date:  1996-08       Impact factor: 3.411

Review 5.  Educational paper: Abusive Head Trauma part I. Clinical aspects.

Authors:  Tessa Sieswerda-Hoogendoorn; Stephen Boos; Betty Spivack; Rob A C Bilo; Rick R van Rijn
Journal:  Eur J Pediatr       Date:  2011-10-28       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.